Effectiveness of the Treatment for Infant Iron Deficiency Anemia by Taking Lactoferrin and Ferralia
- Conditions
- Iron Deficiency Anemia
- Interventions
- Other: Standard infant fomulaOther: Low level LF infant formulaOther: High level LF infant formula
- Registration Number
- NCT03534089
- Lead Sponsor
- Beingmate Baby & Child Food Co Ltd .
- Brief Summary
A multi-center,randomized,double-blind,controlled clinical trial was used to investigate the effectiveness of the treatment of infant iron deficiency anemia by taking ferralia and different contents lactoferrin.
- Detailed Description
5-9 months old infants with iron deficiency anemia were randomly divided into three groups. On the basis of giving the same dose of ferralia,three different levels lactoferrin infant formula were intervened 3 months respectively,and evaluate the clinical effect.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 135
- Full term,healthy infants at 37-42 weeks of gestational age
- 5-9 months old infants were diagnose as iron deficiency anemia
- Accepting bottle feeding
- Hb<60 g/L
- Other microcytic, hypochromic anemia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard infant fomula Standard infant fomula Infants with iron deficiency anemia randomly divided into this arm were given the same dose of ferralia with other arms,but were fed with standard infant formula (without lactoferrin supplementation) Low level LF infant formula group Low level LF infant formula Infants with iron deficiency anemia randomly divided into this arm were given the same dose of ferralia with other arms,but were fed with infant formula supplemented with low level of lactoferrin (38mg/100g). Lactoferrin:38mg/100g High level LF infant formula group High level LF infant formula Infants with iron deficiency anemia randomly divided into this arm were given the same dose of ferralia with other arms,but were fed with infant formula supplemented with high level of lactoferrin (76mg/100g)
- Primary Outcome Measures
Name Time Method Changes of Hb concentration(g/L) Change of Hb concentration from baseline at 1 month and 3 months. Hb was measured by the hemoglobincyanide method
- Secondary Outcome Measures
Name Time Method Change of head circumference (millimeters) Changes of body weight from baseline at 1 month and 3 months. Head circumference detected by measuring tape
Change of serum transferrin receptor concentration(mg/L) Changes of serum transferrin receptor concentration from baseline at 3 months. Serum soluble transferrin receptor (sTfR, mg/L) was measured by microparticle-enhanced immunoassay (Sunbiote, Shanghai, China)
Change of body length (meters) Changes of body weight from baseline at 1 month and 3 months. Body length is detected by infant height bed
Change of serum ferritin concentration (μg/L) Changes of serum iron concentration from baseline at 3 months. concentrations of serum ferritin (SF,μg/L) were measured using a commercial enzyme-linked immunosorbent assay (ELISA; Sunbiote, Shanghai, China).
Change of body weight (kilograms) Changes of body weight from baseline at 1 month and 3 months. Body weight is detected by electronic scale
Trial Locations
- Locations (1)
Chengdu Women's and Children's Central Hospital
🇨🇳Chengdu, China